Researchers have completed the first gene therapy procedure aimed at stopping age-related macular degeneration.
The operation was performed at John Radcliffe Hospital, Oxford, England, by Robert MacLaren, FRCOphth, a professor of ophthalmology at the University of Oxford.
This activity is supported by educational grants from Alcon Laboratories, Inc.; Bausch + Lomb; Carl Zeiss Meditec, Inc.; and J & J Vision.
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2019 Healio All Rights Reserved.